Autotransfusion Systems Market Scope
Autotransfusion systems collect and process a patient's own blood during surgery, thus helping the patient avoid transfusions with donor or banked blood. The increasing number of surgical & transplant procedures worldwide and the advantages of autotransfusion systems are the major drivers fueling the growth of the market.
The Autotransfusion Systems market study is segmented by Type (Intraoperative Autotransfusion Systems and Postoperative Autotransfusion Systems), by Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures and Other) and major geographies with country level break-up.
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Autotransfusion Systems market throughout the predicted period.
Haemonetics Corporation (United States), LivaNova Plc (United States), Medtronic (United States), Redax (Italy), Sarstedt (Germany), Terumo BCT (United States), Atrium Medical Corporation (A Part of Getinge Group) (United States), Becton, Dickinson and Company (United States), Beijing ZKSK Technology Co., Ltd. (China), Braile Biomédica (Brazil), Fresenius Medical Care AG & Co. KGaA (Germany), Gen World Medical Devices (India), Teleflex Incorporated (United States) and Zimmer Biomet Holdings Inc. (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Autotransfusion Systems market by Type, Application and Region.
On the basis of geography, the market of Autotransfusion Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 2 Oct 2017, LivaNova PLC, a market-leading medical technology company, announced its innovative autotransfusion system (ATS), XTRA, has treated its one-millionth patient at Houston Methodist Hospital in Houston (United States).
Market Trend
- Development of Low-Cost Autotransfusion Devices
Market Drivers
- Increasing Number of Surgical & Transplant Procedures Worldwide
- Advantages of Autotransfusion Systems Propelling the Demand
- Scarcity of Donated Blood/Allogenic Blood
Opportunities
- Emerging Economies are expected to Open Massive Demand during the Projected Period
Restraints
- High Costs Associated With Autotransfusion Systems
- Government Initiatives to Streamline the Allogenic/Donated Blood Supply
Challenges
- Scarcity of Resources Such as Well-Trained Perfusionists and Surgical Technicians in Developing Countries
Key Target Audience
Autotransfusion systems Manufacturers, Autotransfusion systems Traders/Distributors, Autotransfusion systems Importer/Exporters, Regulatory & Government Bodies, Research & Consulting Firms, End Users and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase